PHAT Competitors & Alternatives
Compare Phathom Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
PHAT
Main Stock$10.92
Tradestie Score
60
Market Cap
$871.90M
Revenue Growth
1.0%
Analyst Upside
+117.1%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$13.77
|
$1.05B | 72.9 | 60 | Compare |
|
MDXG
MiMedx Group, Inc
|
$4.08
|
$1.01B | 20.6 | 65 | Compare |
|
SPRY
ARS Pharmaceuticals, Inc. Common Stock
|
$7.74
|
$997.16M | - | 55 | Compare |
|
PRME
Prime Medicine, Inc. Common Stock
|
$3.52
|
$996.55M | - | 58 | Compare |
|
SYRE
Spyre Therapeutics, Inc. Common Stock
|
$93.73
|
$994.20M | - | 62 | Compare |
|
VALN
Valneva SE American Depositary Shares
|
$5.26
|
$993.46M | - | 62 | Compare |
|
IMNM
Immunome, Inc.
|
$22.80
|
$987.09M | - | 62 | Compare |
|
BBOT
BridgeBio Oncology Therapeutics, Inc. Common Stock
|
$8.52
|
$952.74M | - | 58 | Compare |
|
SANA
Sana Biotechnology, Inc. Common Stock
|
$3.64
|
$951.83M | - | 61 | Compare |
|
MNMD
Mind Medicine (MindMed) Inc. Common Shares
|
$15.02
|
$938.16M | - | 62 | Compare |
More PHAT Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry